A股異動丨中牧股份大跌近9% 旗下疫苗廠排放不達標導致蘭州布病事件
格隆匯12月27日丨中牧股份(600195.SH)大跌近9%,報11.45元,總市值96.5億元。昨日晚間,甘肅省政府、衞健委以及農業農村廳聯合發佈中國農科院蘭州獸研所布魯氏菌抗體陽性事件調查處置情況通報。通報稱,造成蘭州獸研所布魯氏菌抗體陽性事件的“罪魁禍首”系與其相鄰的中牧蘭州生物藥廠獸用布魯氏菌疫苗生產車間。專家組認為:2019年7月24日至8月20日,中牧蘭州生物藥廠在獸用布魯氏菌疫苗生產過程中使用過期消毒劑,致使生產發酵罐廢氣排放滅菌不徹底,攜帶含菌發酵液的廢氣形成含菌氣溶膠,生產時段該區域主風向為東南風,蘭州獸研所處在中牧蘭州生物藥廠的下風向,人體吸入或粘膜接觸產生抗體陽性,造成蘭州獸研所發生布魯氏菌抗體陽性事件。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.